Key points are not available for this paper at this time.
Follow-up Data and the Free IntervalAfter the primary treatment, the patient enters an interval free of overt disease. In approximately half of all patients treated for cancer of the breast, this interval will last for the rest of her life. Whatever its duration, the patient has several problems to face: cosmetic factors; radiation; surgical menopause; the opposite breast; and follow-up examination for recurrence.As for the opposite breast, figures for recurrence range from 7 to 12 per cent, always with some lingering confusion over whether the second breast is involved by metastases or new primary disease. Among the . . .
Moore et al. (Thu,) studied this question.